跳至主要内容
临床试验/CTRI/2023/10/058232
CTRI/2023/10/058232尚未招募2 期

A Randomized Controlled Clinical study to evaluate the efficacy of Durvadi Tailam Suppository in the management of Anal Pain in Parikartika in Young adults with special reference to Anal Fissure. - NI

Dr SHATTARKA G MAHADIK0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients presenting with anal pain and two or more other complaints like bleeding per rectum, painful defecation, constipation and pruritis for a duration of = 6 months.
  • 2.Patients clinically diagnosed of having Acute and Chronic Anal Fissure for a duration of = 6 months presenting with anal pain and two or more other complaints like bleeding per rectum, painful defecation, constipation and pruritis.
  • 3.Patients of either sex will be included.
  • 4.Age 18-60 years old patients included.
  • 5.Patients ready to give informed written consent.
  • 6.Patients ready to abide by the trail procedures meant for this study.

排除标准

  • 1.Known cases or suspected cases Irritable Bowel Diseases- Ulcerative diseases and Chron’s diseases.
  • 2.Patients below 18 years and above 60 years of age.
  • 3.Patients with known cases of other Anal conditions like Inflamed or infected Sentinel pile (External tag), Hemorrhoids, Fistula in Ano, Abscess, Proctitis, Malignancy, etc.
  • 4. Patients with following medical conditions requiring stringent medications like
  • o Hematological conditions- Anemia, thrombocytopenia and bleeding disorders. Poorly controlled hypertension ( >160/100 mm Hg)
  • o Uncontrolled diabetes mellitus having hemoglobin A1c (HbA1c) > 8%
  • o With concurrent serious hepatic disorders (defined as aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) > 2 times upper normal limit)
  • o With Renal disorders (defined as serum creatinine > 1.2 mg/dL),
  • o With severe pulmonary dysfunction (uncontrolled bronchial asthma and/or chronic obstructive pulmonary disease (COPD))
  • o Acute and generalized spreading infections
  • o With Immunocompromised status.
  • 5. Patients on medication with corticosteroids, phototherapy, radiotherapy, chemotherapy, biologics, antidepressants, and any other drugs that may have an influence on the outcome of the study.
  • 6. Pregnant females.
  • 7.History of hypersensitivity to any of the trial drugs or their ingredients.

研究者

发起方
Dr SHATTARKA G MAHADIK

相似试验